nodes	percent_of_prediction	percent_of_DWPC	metapath
Carglumic Acid—CPS1—Podofilox—Etoposide—peripheral nervous system neoplasm	0.0642	1	CbGdCrCtD
Carglumic Acid—Transaminases increased—Melphalan—peripheral nervous system neoplasm	0.0234	0.025	CcSEcCtD
Carglumic Acid—Nasopharyngitis—Tretinoin—peripheral nervous system neoplasm	0.00936	0.01	CcSEcCtD
Carglumic Acid—Nasopharyngitis—Isotretinoin—peripheral nervous system neoplasm	0.00936	0.01	CcSEcCtD
Carglumic Acid—Sweating increased—Tretinoin—peripheral nervous system neoplasm	0.00882	0.00942	CcSEcCtD
Carglumic Acid—Sweating increased—Isotretinoin—peripheral nervous system neoplasm	0.00882	0.00942	CcSEcCtD
Carglumic Acid—Weight decreased—Tretinoin—peripheral nervous system neoplasm	0.00819	0.00875	CcSEcCtD
Carglumic Acid—Weight decreased—Isotretinoin—peripheral nervous system neoplasm	0.00819	0.00875	CcSEcCtD
Carglumic Acid—Pneumonia—Topotecan—peripheral nervous system neoplasm	0.00818	0.00874	CcSEcCtD
Carglumic Acid—Infestation NOS—Topotecan—peripheral nervous system neoplasm	0.00813	0.00869	CcSEcCtD
Carglumic Acid—Infestation—Topotecan—peripheral nervous system neoplasm	0.00813	0.00869	CcSEcCtD
Carglumic Acid—Pneumonia—Isotretinoin—peripheral nervous system neoplasm	0.00812	0.00867	CcSEcCtD
Carglumic Acid—Pneumonia—Tretinoin—peripheral nervous system neoplasm	0.00812	0.00867	CcSEcCtD
Carglumic Acid—Infestation NOS—Isotretinoin—peripheral nervous system neoplasm	0.00807	0.00862	CcSEcCtD
Carglumic Acid—Infestation—Isotretinoin—peripheral nervous system neoplasm	0.00807	0.00862	CcSEcCtD
Carglumic Acid—Infestation—Tretinoin—peripheral nervous system neoplasm	0.00807	0.00862	CcSEcCtD
Carglumic Acid—Infestation NOS—Tretinoin—peripheral nervous system neoplasm	0.00807	0.00862	CcSEcCtD
Carglumic Acid—Transaminases increased—Epirubicin—peripheral nervous system neoplasm	0.00786	0.0084	CcSEcCtD
Carglumic Acid—Transaminases increased—Doxorubicin—peripheral nervous system neoplasm	0.00728	0.00777	CcSEcCtD
Carglumic Acid—Nasopharyngitis—Alitretinoin—peripheral nervous system neoplasm	0.0071	0.00758	CcSEcCtD
Carglumic Acid—Sweating increased—Alitretinoin—peripheral nervous system neoplasm	0.00668	0.00714	CcSEcCtD
Carglumic Acid—Pneumonia—Dactinomycin—peripheral nervous system neoplasm	0.00663	0.00709	CcSEcCtD
Carglumic Acid—Malnutrition—Topotecan—peripheral nervous system neoplasm	0.00636	0.00679	CcSEcCtD
Carglumic Acid—Malnutrition—Isotretinoin—peripheral nervous system neoplasm	0.00631	0.00674	CcSEcCtD
Carglumic Acid—Malnutrition—Tretinoin—peripheral nervous system neoplasm	0.00631	0.00674	CcSEcCtD
Carglumic Acid—Weight decreased—Alitretinoin—peripheral nervous system neoplasm	0.00621	0.00663	CcSEcCtD
Carglumic Acid—Pneumonia—Alitretinoin—peripheral nervous system neoplasm	0.00615	0.00657	CcSEcCtD
Carglumic Acid—Infestation NOS—Alitretinoin—peripheral nervous system neoplasm	0.00612	0.00654	CcSEcCtD
Carglumic Acid—Infestation—Alitretinoin—peripheral nervous system neoplasm	0.00612	0.00654	CcSEcCtD
Carglumic Acid—Nasopharyngitis—Cisplatin—peripheral nervous system neoplasm	0.00605	0.00646	CcSEcCtD
Carglumic Acid—Weight decreased—Vincristine—peripheral nervous system neoplasm	0.00598	0.00639	CcSEcCtD
Carglumic Acid—Pneumonia—Vincristine—peripheral nervous system neoplasm	0.00593	0.00633	CcSEcCtD
Carglumic Acid—Anaemia—Topotecan—peripheral nervous system neoplasm	0.00588	0.00628	CcSEcCtD
Carglumic Acid—Anaemia—Tretinoin—peripheral nervous system neoplasm	0.00583	0.00623	CcSEcCtD
Carglumic Acid—Anaemia—Isotretinoin—peripheral nervous system neoplasm	0.00583	0.00623	CcSEcCtD
Carglumic Acid—Anaemia—Melphalan—peripheral nervous system neoplasm	0.00575	0.00615	CcSEcCtD
Carglumic Acid—Sweating increased—Cisplatin—peripheral nervous system neoplasm	0.00569	0.00608	CcSEcCtD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Topotecan—peripheral nervous system neoplasm	0.00537	0.00574	CcSEcCtD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Tretinoin—peripheral nervous system neoplasm	0.00533	0.0057	CcSEcCtD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Isotretinoin—peripheral nervous system neoplasm	0.00533	0.0057	CcSEcCtD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Melphalan—peripheral nervous system neoplasm	0.00526	0.00562	CcSEcCtD
Carglumic Acid—Sweating increased—Etoposide—peripheral nervous system neoplasm	0.00522	0.00557	CcSEcCtD
Carglumic Acid—Infection—Topotecan—peripheral nervous system neoplasm	0.00515	0.00551	CcSEcCtD
Carglumic Acid—Infection—Tretinoin—peripheral nervous system neoplasm	0.00511	0.00546	CcSEcCtD
Carglumic Acid—Infection—Isotretinoin—peripheral nervous system neoplasm	0.00511	0.00546	CcSEcCtD
Carglumic Acid—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.00509	0.00544	CcSEcCtD
Carglumic Acid—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.00505	0.00539	CcSEcCtD
Carglumic Acid—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.00505	0.00539	CcSEcCtD
Carglumic Acid—Infection—Melphalan—peripheral nervous system neoplasm	0.00505	0.00539	CcSEcCtD
Carglumic Acid—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.00504	0.00539	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Topotecan—peripheral nervous system neoplasm	0.00502	0.00536	CcSEcCtD
Carglumic Acid—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.005	0.00534	CcSEcCtD
Carglumic Acid—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.005	0.00534	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Tretinoin—peripheral nervous system neoplasm	0.00498	0.00532	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Isotretinoin—peripheral nervous system neoplasm	0.00498	0.00532	CcSEcCtD
Carglumic Acid—Anorexia—Topotecan—peripheral nervous system neoplasm	0.00495	0.00528	CcSEcCtD
Carglumic Acid—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.00493	0.00527	CcSEcCtD
Carglumic Acid—Cardiac disorder—Vincristine—peripheral nervous system neoplasm	0.00491	0.00525	CcSEcCtD
Carglumic Acid—Anorexia—Tretinoin—peripheral nervous system neoplasm	0.00491	0.00524	CcSEcCtD
Carglumic Acid—Anorexia—Isotretinoin—peripheral nervous system neoplasm	0.00491	0.00524	CcSEcCtD
Carglumic Acid—Anorexia—Melphalan—peripheral nervous system neoplasm	0.00484	0.00517	CcSEcCtD
Carglumic Acid—Pneumonia—Etoposide—peripheral nervous system neoplasm	0.0048	0.00513	CcSEcCtD
Carglumic Acid—Malnutrition—Alitretinoin—peripheral nervous system neoplasm	0.00478	0.00511	CcSEcCtD
Carglumic Acid—Infestation NOS—Etoposide—peripheral nervous system neoplasm	0.00477	0.0051	CcSEcCtD
Carglumic Acid—Infestation—Etoposide—peripheral nervous system neoplasm	0.00477	0.0051	CcSEcCtD
Carglumic Acid—Anaemia—Dactinomycin—peripheral nervous system neoplasm	0.00476	0.00509	CcSEcCtD
Carglumic Acid—Bradycardia—Cisplatin—peripheral nervous system neoplasm	0.00476	0.00509	CcSEcCtD
Carglumic Acid—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.00458	0.00489	CcSEcCtD
Carglumic Acid—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.00458	0.00489	CcSEcCtD
Carglumic Acid—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.00451	0.00482	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.00448	0.00479	CcSEcCtD
Carglumic Acid—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.00447	0.00478	CcSEcCtD
Carglumic Acid—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.00447	0.00478	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.00444	0.00475	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.00444	0.00475	CcSEcCtD
Carglumic Acid—Anaemia—Alitretinoin—peripheral nervous system neoplasm	0.00442	0.00472	CcSEcCtD
Carglumic Acid—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.00442	0.00472	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.00439	0.00469	CcSEcCtD
Carglumic Acid—Cardiac disorder—Cisplatin—peripheral nervous system neoplasm	0.00434	0.00464	CcSEcCtD
Carglumic Acid—Anaemia—Vincristine—peripheral nervous system neoplasm	0.00426	0.00455	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.00424	0.00453	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.00421	0.0045	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.00421	0.0045	CcSEcCtD
Carglumic Acid—Infection—Dactinomycin—peripheral nervous system neoplasm	0.00418	0.00447	CcSEcCtD
Carglumic Acid—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.0041	0.00438	CcSEcCtD
Carglumic Acid—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.0041	0.00438	CcSEcCtD
Carglumic Acid—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.00407	0.00435	CcSEcCtD
Carglumic Acid—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00407	0.00435	CcSEcCtD
Carglumic Acid—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00407	0.00435	CcSEcCtD
Carglumic Acid—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.00407	0.00435	CcSEcCtD
Carglumic Acid—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.00407	0.00435	CcSEcCtD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.00404	0.00432	CcSEcCtD
Carglumic Acid—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.00401	0.00428	CcSEcCtD
Carglumic Acid—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.00398	0.00425	CcSEcCtD
Carglumic Acid—Infection—Alitretinoin—peripheral nervous system neoplasm	0.00387	0.00414	CcSEcCtD
Carglumic Acid—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.00382	0.00409	CcSEcCtD
Carglumic Acid—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.00379	0.00405	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.00377	0.00403	CcSEcCtD
Carglumic Acid—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.00376	0.00402	CcSEcCtD
Carglumic Acid—Infection—Vincristine—peripheral nervous system neoplasm	0.00373	0.00399	CcSEcCtD
Carglumic Acid—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00372	0.00398	CcSEcCtD
Carglumic Acid—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.00372	0.00397	CcSEcCtD
Carglumic Acid—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00369	0.00395	CcSEcCtD
Carglumic Acid—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00369	0.00395	CcSEcCtD
Carglumic Acid—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.00369	0.00394	CcSEcCtD
Carglumic Acid—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.00366	0.00391	CcSEcCtD
Carglumic Acid—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.00365	0.0039	CcSEcCtD
Carglumic Acid—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00364	0.00389	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.00363	0.00388	CcSEcCtD
Carglumic Acid—Anorexia—Vincristine—peripheral nervous system neoplasm	0.00358	0.00383	CcSEcCtD
Carglumic Acid—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00355	0.00379	CcSEcCtD
Carglumic Acid—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00352	0.00376	CcSEcCtD
Carglumic Acid—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00352	0.00376	CcSEcCtD
Carglumic Acid—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00348	0.00371	CcSEcCtD
Carglumic Acid—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00347	0.00371	CcSEcCtD
Carglumic Acid—Anaemia—Etoposide—peripheral nervous system neoplasm	0.00345	0.00368	CcSEcCtD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.00344	0.00368	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00344	0.00368	CcSEcCtD
Carglumic Acid—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00339	0.00362	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00337	0.0036	CcSEcCtD
Carglumic Acid—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00333	0.00355	CcSEcCtD
Carglumic Acid—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00333	0.00355	CcSEcCtD
Carglumic Acid—Infection—Cisplatin—peripheral nervous system neoplasm	0.0033	0.00353	CcSEcCtD
Carglumic Acid—Vomiting—Topotecan—peripheral nervous system neoplasm	0.0033	0.00353	CcSEcCtD
Carglumic Acid—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00327	0.0035	CcSEcCtD
Carglumic Acid—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00327	0.0035	CcSEcCtD
Carglumic Acid—Rash—Topotecan—peripheral nervous system neoplasm	0.00327	0.0035	CcSEcCtD
Carglumic Acid—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00327	0.00349	CcSEcCtD
Carglumic Acid—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00327	0.00349	CcSEcCtD
Carglumic Acid—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00326	0.00348	CcSEcCtD
Carglumic Acid—Headache—Topotecan—peripheral nervous system neoplasm	0.00325	0.00347	CcSEcCtD
Carglumic Acid—Rash—Tretinoin—peripheral nervous system neoplasm	0.00324	0.00347	CcSEcCtD
Carglumic Acid—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00324	0.00347	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00324	0.00347	CcSEcCtD
Carglumic Acid—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00324	0.00346	CcSEcCtD
Carglumic Acid—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00324	0.00346	CcSEcCtD
Carglumic Acid—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00323	0.00345	CcSEcCtD
Carglumic Acid—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.00323	0.00345	CcSEcCtD
Carglumic Acid—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00322	0.00345	CcSEcCtD
Carglumic Acid—Headache—Tretinoin—peripheral nervous system neoplasm	0.00322	0.00345	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00321	0.00343	CcSEcCtD
Carglumic Acid—Rash—Melphalan—peripheral nervous system neoplasm	0.0032	0.00342	CcSEcCtD
Carglumic Acid—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.0032	0.00342	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00319	0.00341	CcSEcCtD
Carglumic Acid—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.00317	0.00339	CcSEcCtD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.00315	0.00337	CcSEcCtD
Carglumic Acid—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.0031	0.00332	CcSEcCtD
Carglumic Acid—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00308	0.00329	CcSEcCtD
Carglumic Acid—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00308	0.00329	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00307	0.00328	CcSEcCtD
Carglumic Acid—Infection—Etoposide—peripheral nervous system neoplasm	0.00302	0.00323	CcSEcCtD
Carglumic Acid—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00302	0.00323	CcSEcCtD
Carglumic Acid—Influenza—Epirubicin—peripheral nervous system neoplasm	0.003	0.00321	CcSEcCtD
Carglumic Acid—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00297	0.00317	CcSEcCtD
Carglumic Acid—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00297	0.00317	CcSEcCtD
Carglumic Acid—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.00296	0.00316	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00294	0.00315	CcSEcCtD
Carglumic Acid—Anorexia—Etoposide—peripheral nervous system neoplasm	0.0029	0.0031	CcSEcCtD
Carglumic Acid—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00289	0.00309	CcSEcCtD
Carglumic Acid—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00288	0.00308	CcSEcCtD
Carglumic Acid—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.00287	0.00307	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00287	0.00307	CcSEcCtD
Carglumic Acid—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.0028	0.00299	CcSEcCtD
Carglumic Acid—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.00278	0.00297	CcSEcCtD
Carglumic Acid—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.00272	0.0029	CcSEcCtD
Carglumic Acid—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00271	0.00289	CcSEcCtD
Carglumic Acid—Asthenia—Vincristine—peripheral nervous system neoplasm	0.0027	0.00288	CcSEcCtD
Carglumic Acid—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.00269	0.00288	CcSEcCtD
Carglumic Acid—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.00268	0.00286	CcSEcCtD
Carglumic Acid—Infestation—Epirubicin—peripheral nervous system neoplasm	0.00268	0.00286	CcSEcCtD
Carglumic Acid—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00267	0.00286	CcSEcCtD
Carglumic Acid—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00267	0.00285	CcSEcCtD
Carglumic Acid—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00265	0.00283	CcSEcCtD
Carglumic Acid—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00265	0.00283	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00263	0.00281	CcSEcCtD
Carglumic Acid—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00263	0.00281	CcSEcCtD
Carglumic Acid—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00257	0.00275	CcSEcCtD
Carglumic Acid—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.00251	0.00268	CcSEcCtD
Carglumic Acid—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.00249	0.00266	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00249	0.00266	CcSEcCtD
Carglumic Acid—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00248	0.00265	CcSEcCtD
Carglumic Acid—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.00248	0.00265	CcSEcCtD
Carglumic Acid—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.00248	0.00265	CcSEcCtD
Carglumic Acid—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00246	0.00263	CcSEcCtD
Carglumic Acid—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00246	0.00263	CcSEcCtD
Carglumic Acid—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.00245	0.00261	CcSEcCtD
Carglumic Acid—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00244	0.00261	CcSEcCtD
Carglumic Acid—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00241	0.00257	CcSEcCtD
Carglumic Acid—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00241	0.00257	CcSEcCtD
Carglumic Acid—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00239	0.00255	CcSEcCtD
Carglumic Acid—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00238	0.00255	CcSEcCtD
Carglumic Acid—Rash—Vincristine—peripheral nervous system neoplasm	0.00237	0.00253	CcSEcCtD
Carglumic Acid—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00237	0.00253	CcSEcCtD
Carglumic Acid—Headache—Vincristine—peripheral nervous system neoplasm	0.00235	0.00252	CcSEcCtD
Carglumic Acid—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00227	0.00243	CcSEcCtD
Carglumic Acid—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.00226	0.00242	CcSEcCtD
Carglumic Acid—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.00223	0.00238	CcSEcCtD
Carglumic Acid—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00218	0.00233	CcSEcCtD
Carglumic Acid—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00211	0.00226	CcSEcCtD
Carglumic Acid—Rash—Cisplatin—peripheral nervous system neoplasm	0.0021	0.00224	CcSEcCtD
Carglumic Acid—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00209	0.00224	CcSEcCtD
Carglumic Acid—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.00209	0.00223	CcSEcCtD
Carglumic Acid—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00208	0.00223	CcSEcCtD
Carglumic Acid—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.00206	0.0022	CcSEcCtD
Carglumic Acid—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.00205	0.00219	CcSEcCtD
Carglumic Acid—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00194	0.00207	CcSEcCtD
Carglumic Acid—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.00193	0.00207	CcSEcCtD
Carglumic Acid—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.00193	0.00207	CcSEcCtD
Carglumic Acid—Rash—Etoposide—peripheral nervous system neoplasm	0.00192	0.00205	CcSEcCtD
Carglumic Acid—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00192	0.00205	CcSEcCtD
Carglumic Acid—Headache—Etoposide—peripheral nervous system neoplasm	0.00191	0.00204	CcSEcCtD
Carglumic Acid—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.00189	0.00202	CcSEcCtD
Carglumic Acid—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.00179	0.00191	CcSEcCtD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.00177	0.00189	CcSEcCtD
Carglumic Acid—Infection—Epirubicin—peripheral nervous system neoplasm	0.0017	0.00181	CcSEcCtD
Carglumic Acid—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.00167	0.00179	CcSEcCtD
Carglumic Acid—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.00166	0.00177	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.00165	0.00176	CcSEcCtD
Carglumic Acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.00164	0.00175	CcSEcCtD
Carglumic Acid—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.00163	0.00174	CcSEcCtD
Carglumic Acid—Infection—Doxorubicin—peripheral nervous system neoplasm	0.00157	0.00168	CcSEcCtD
Carglumic Acid—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00155	0.00165	CcSEcCtD
Carglumic Acid—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.00153	0.00164	CcSEcCtD
Carglumic Acid—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.00153	0.00163	CcSEcCtD
Carglumic Acid—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.00152	0.00162	CcSEcCtD
Carglumic Acid—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.00151	0.00161	CcSEcCtD
Carglumic Acid—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.00148	0.00159	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00147	0.00157	CcSEcCtD
Carglumic Acid—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.0014	0.0015	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.0014	0.00149	CcSEcCtD
Carglumic Acid—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.00137	0.00147	CcSEcCtD
Carglumic Acid—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00136	0.00146	CcSEcCtD
Carglumic Acid—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.00135	0.00144	CcSEcCtD
Carglumic Acid—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.00135	0.00144	CcSEcCtD
Carglumic Acid—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.00129	0.00138	CcSEcCtD
Carglumic Acid—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.00125	0.00133	CcSEcCtD
Carglumic Acid—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.00125	0.00133	CcSEcCtD
Carglumic Acid—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.00122	0.00131	CcSEcCtD
Carglumic Acid—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.00117	0.00125	CcSEcCtD
Carglumic Acid—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.00113	0.00121	CcSEcCtD
Carglumic Acid—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00109	0.00116	CcSEcCtD
Carglumic Acid—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.00108	0.00115	CcSEcCtD
Carglumic Acid—Rash—Epirubicin—peripheral nervous system neoplasm	0.00108	0.00115	CcSEcCtD
Carglumic Acid—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00108	0.00115	CcSEcCtD
Carglumic Acid—Headache—Epirubicin—peripheral nervous system neoplasm	0.00107	0.00114	CcSEcCtD
Carglumic Acid—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.001	0.00107	CcSEcCtD
Carglumic Acid—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000996	0.00106	CcSEcCtD
Carglumic Acid—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000995	0.00106	CcSEcCtD
Carglumic Acid—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000989	0.00106	CcSEcCtD
